Rock Creek Pharmaceuticals, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Scannell Robert, was filed 31 Mar 2016.
Rock Creek Pharmaceuticals, Inc.: what insiders have been doing
Rock Creek Pharmaceuticals, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). Rock Creek Pharmaceuticals, Inc. has had no insider filing for more than a year; the last one goes back to 31 March 2016.
Looking back to 2006, when coverage begins, insiders filed 52 purchases and 9 sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
- 285,714 shares@ US$0.35100.0% of flowCommon StockSEC:0001140361-16-059675:0Canonical exit: 28 Jun 2016 (T+90)
- 1,579,498 shares0Common StockSEC:0001209191-14-025894:0
- 2,219,822 shares0Common StockSEC:0001209191-14-025894:1
- 369,796 shares0Common StockSEC:0001209191-14-025894:2
- 766,808 shares0Common StockSEC:0001209191-14-025894:3
- 1,136,604 shares0Common StockSEC:0001209191-14-025894:4
- 5,625,051 shares0Common StockSEC:0001209191-14-025891:0
- 1,830,646 shares@ US$1.66Common StockSEC:0001181431-13-042647:0
- 750,000 shares@ US$1.34Common StockSEC:0001181431-13-042647:1
- 953,260 shares@ US$2.66Common StockSEC:0001181431-13-003299:0
- 452,359 shares@ US$2.52Common StockSEC:0001181431-13-003299:1
- 1,290,323 shares@ US$1.00Common StockSEC:0001181431-12-062510:0
- 1,000,000 shares@ US$1.50Common StockSEC:0001144204-12-064023:0
- 100,000 shares@ US$1.12Common StockSEC:0001144204-12-032814:0
- 28,141 shares@ US$3.98Common StockSEC:0001144204-12-032814:1
- 10,000 shares@ US$3.92Common StockSEC:0001144204-12-032814:2
- 21,000 shares@ US$3.84Common StockSEC:0001144204-12-032814:3
- 59,500 shares@ US$2.33Common StockSEC:0001209191-11-058110:0Canonical exit: 21 Feb 2012 (T+90)
- 17,972 shares@ US$2.56Common StockSEC:0001209191-11-058110:1Canonical exit: 23 Feb 2012 (T+90)
- 22,528 shares@ US$2.63Common StockSEC:0001209191-11-058110:2Canonical exit: 26 Feb 2012 (T+90)
- 1,100,000 shares0Common StockSEC:0001209191-11-047353:0
- 150,000 shares@ US$1.80Common StockSEC:0001181431-11-047460:0Canonical exit: 24 Nov 2011 (T+90)
- 100,000 shares@ US$1.12Common StockSEC:0001209191-11-031661:0
- 100,000 shares@ US$4.25Common StockSEC:0001209191-11-031661:1
- 50,000 shares@ US$1.47Common StockSEC:0001209191-11-020737:0
25 of 82 declarations
About Rock Creek Pharmaceuticals, Inc.
Rock Creek Pharmaceuticals, Inc. is a company focused on drug development. It is listed on the XNAS market.
